Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience.

@article{Weinstock2016SubcutaneousIC,
  title={Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience.},
  author={Jonathan Weinstock and Yousef H Bader and Martin S. Maron and Ethan J Rowin and Mark S. Link},
  journal={Journal of the American Heart Association},
  year={2016},
  volume={5 2}
}
BACKGROUND The subcutaneous implantable cardioverter defibrillator (S-ICD) has been developed to avert risks associated with transvenous defibrillator leads. The technology is attractive for younger patients, such as those with hypertrophic cardiomyopathy (HCM). However, there are limited data on S-ICD use in HCM. METHODS AND RESULTS HCM patients identified at risk for sudden death were considered for S-ICD implantation. Patients were screened for potential oversensing by surface… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 9 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 16 references

Abstract 12223: ICD defibrillation threshold testing in patients with hypertrophic cardiomyopathy

KR Kumar, SN Mandleywala, +3 authors MS. Link
2014
View 2 Excerpts

How many patients fulfil the surface electrocardiogram criteria for subcutaneous implantable cardioverter-defibrillator implantation?

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology • 2014

Similar Papers

Loading similar papers…